News

FDA Blueprint Aims to Reduce Regulatory Risks for Animal Testing Alternatives

FDA · 6 min

China’s Rise in Drug Development Looms Over U.S. Oncology Market

FDA · oncology · 5 min

FDA Declines Guidance on Foreign Drug Imports: Impact on Pharma BD and Investors

FDA · 6 min

Ophthalmology Pipeline Milestones for Q2 2026: Key Catalysts and Investor Insights

FDA · ophthalmology · 6 min

Vir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM

FDA · 7 min

Real-World Data from EHRs and Claims: Strengths, Limitations, and Regulatory Impact

FDA · 7 min

The Common Fund Data Ecosystem (CFDE)

FDA · 5 min

Physician-Led Patient Education: A Strategy to Mitigate the Gross-to-Net Squeeze

FDA · 8 min

A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain

FDA · 6 min

The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities in 2024

FDA · chronic diseases · 7 min

Opinion: The medical-billing AI arms race between providers and insurance

7 min

Opinion: The Amish Way of Healthcare Offers Lessons for Public Health

7 min